Literature DB >> 34779028

Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapy.

Relja Popovic1, Fengjiao Dunbar1, Charles Lu1, Kenneth Robinson1, Danjuma Quarless1, Scott E Warder1, Nabanita Mukherjee1, John Pesko1, Andrew J Souers1, Jeffrey F Waring1, Matthew S Davids2, Eugen Tausch3, Stephan Stilgenbauer3, Jeremy A Ross1, Joel D Leverson1, Su Young Kim1, Brenda J Chyla1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34779028     DOI： 10.1002/ajh.26411

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors.

Authors:  Ella R Thompson; Tamia Nguyen; Yamuna Kankanige; John F Markham; Mary Ann Anderson; Sasanka M Handunnetti; Rachel Thijssen; Paul Sung-Hao Yeh; Constantine S Tam; John F Seymour; Andrew W Roberts; David A Westerman; Piers Blombery
Journal:  Blood Adv       Date:  2022-01-25

Review 2.  Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma.

Authors:  Yvonne J Thus; Eric Eldering; Arnon P Kater; Marcel Spaargaren
Journal:  Leukemia       Date:  2022-06-20       Impact factor: 12.883
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.